“You Can’t Just Be an Oncologist” Given PBM Concerns, Legal Issues
Legal concerns over cancer drug delivery and growing costs associated with PBMs mean “you can’t just be an oncologist,” says Ted Okon, executive director of COA.
Legal concerns over cancer drug delivery and growing costs associated with PBMs mean “you can’t just be an oncologist,” says Ted Okon, executive director of COA.
The OncoAlert Newsletter is now out for June 23-29, 2023
First-of-its-kind trial suggests CRISPR acting inside the body can be safe and effective
Alsop has had enviable success, and was the first female conductor to lead a top American orchestra. She wants to take another step up.
Objective We identified mechanisms for addressing and/or managing the influence of corporations on public health policy, research and practice, as well as examples of where…
Tumor Board Tuesdays is a regularly scheduled, Twitter-based case discussion forum led by expert faculty exploring cases in various solid tumor malignancies. The series will…
Trying to remove politics from the NHS is akin to trying to block out the sun, please can we start to harness its power for…
Sarah Manavis and her partner have a guilty secret. What they love to do most of all in private is… read out loud to each…
Sameer Jauhar and Paul Morrison consider the revised #UnderstandingPsychosis and Schizophrenia report from the BPS Division of Clinical Psychology.
Non-Hodgkin’s lymphomas (NHLs) are a heterogeneous group of lymphoproliferative disorders originating from B, T, or NK lymphocytes. They represent approximately 4–5% of new cancer cases…